Steffi Elisabeth Maria van de Ven

11PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 20, 2024
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessment.

Laurelle van Tilburg, Eva P D Verheij, Steffi E M van de Ven

|Jun 16, 2023
Endoscopic screening of the upper gastrointestinal tract for second primary tumors in patients with head and neck cancer in a Western country.

Laurelle van Tilburg, Steffi E M van de Ven, Pieter Jan F de Jonge

|Oct 05, 2021
Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma.

Steffi E M van de Ven, Lucia Suzuki, Annieke W Gotink

|Sep 30, 2021
Extending treatment criteria for Barrett's neoplasia: results of a nationwide cohort of 138 endoscopic submucosal dissection procedures.

Sanne N van Munster, Eva P D Verheij, Esther A Nieuwenhuis

|Jun 01, 2021
Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett's neoplasia.

Sanne N van Munster, Charlotte N Frederiks, Esther A Nieuwenhuis

|Mar 23, 2021
Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period.

Sanne van Munster, Esther Nieuwenhuis, Bas L A M Weusten

Pageof 2

Frequent Collaborators

3 joint publications

Laurelle van Tilburg

2 joint publications

Manon C W Spaander

2 joint publications

Sybren L Meijer

2 joint publications

Sanne N van Munster